Health Care & Life Sciences » Biotechnology | Avivagen Inc.

Avivagen Inc.

Avivagen Inc.
Stock Exchange Other OTC
EPS
 $0.11
Market Cap
 $17.45 M
Shares Outstanding
 33.27 M
Public Float
 -
Avivagen Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
 CAD0.15
Market Cap
 CAD22.49 M
Shares Outstanding
 27.26 M
Public Float
 22.44 M

Profile

Address
100 Sussex Drive
Ottawa Ontario K1A 0R6
Canada
Employees -
Website http://www.avivagen.com
Updated 07/08/2019
Avivagen, Inc. engages in the development and commercialization of products for livestock. Its products include OxC-beta Livestock, Vivamune Vital Health Chews and Oximunol Chewable Tablets. The company was founded by Janusz Daroszewsk and Graham W.

Financials

View All

G. F. Kym Anthony
Chairman, President & Chief Executive Officer
Graham W. Burton
Director & Chief Scientific Officer
View All

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.